Under the terms of the agreement, Novartis will pay $925 million upfront and up to $2.15 billion, contingent upon achievement ...

Novartis is paying $925 million upfront to acquire Anthos Therapeutics, whose launch the pharma backed in February 2019.

LEXINGTON, Mass. - Voyager Therapeutics, Inc. (NASDAQ:VYGR), a biotechnology firm focused on neurogenetic medicines with a market capitalization of $290 million, announced today it is reassessing its ...

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...

Under Armour Inc. Cl C-0.67% $3.01B Under Armour Inc. Cl A-0.76% $3.01B ...

Petroleo Brasileiro S/A Ord 0.83% R$493.53B Petroleo Brasileiro S/A Pref 0.68% R$493.53B ...

Investing.com -- 瑞士制药公司诺华周二宣布，已达成协议收购生物制药公司Anthos Therapeutics。 根据公司声明，此次收购将包括诺华支付9.25亿美元的首付款，以及最高可达21.5亿美元的额外付款。

Making the world smarter, happier, and richer.

Nearly 30% of midcap & small-cap stocks are at/near 52-week lows 99% of midcap & 95% of small-cap 100 stocks close with cuts today ...